Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Arzneimittel-Forschung|March 7, 2002
General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscleHirohiko Arisawa, Kenji Fukui, Nobuaki Fujise, et al.Liver|September 26, 2002
Reduction of monocrotaline-induced hepatic injury by deleted variant of hepatocyte growth factor (dHGF) in ratsYasushi Yamashita, Nobuaki Fujise, Eiichi Imai, et al.Journal of Bone and Mineral Metabolism|January 26, 2002
Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized ratsShin-ichi Mochizuki, Nobuaki Fujise, Kanji Higashio, et al.Arzneimittel-Forschung|February 13, 2002
General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous systemHirohiko Arisawa, Eiichi Imai, Nobuaki Fujise, et al.Arzneimittel-Forschung|June 4, 2002
General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effectsHirohiko Arisawa, Kenji Fukui, Eiichi Imai, et al.The Journal of Antibiotics|March 29, 2002
SNF4435C and D, novel immunosuppressants produced by a strain of Streptomyces spectabilis. III. Immunosuppressive efficacyKazuhiko Kurosawa, Kosaku Takahashi, Nobuaki Fujise, et al.JPEN. Journal of Parenteral and Enteral Nutrition|April 28, 2007
An antioxidative nutrient-rich enteral diet attenuates lethal activity and oxidative stress induced by lipopolysaccharide in miceShizuko Abe, Yoshiaki Tanaka, Nobuaki Fujise, et al.Journal of Bone and Mineral Metabolism|November 16, 2002
Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosisAtsuko Mizuno, Takeshi Kanno, Masaki Hoshi, et al.Pageof 1